In 1989 the BCDRC was established by the Minister of National Defence and is mandated to review annually the research, development and training activities in Biological and Chemical Defence undertaken by DND and the CAF. The review is conducted to ensure that all activities are defensive in nature and conducted in a professional manner with no threat to public safety or the environment. On 10 June 2014, the Biological and Chemical Defence Review Committee (BCDRC) visited RMCC as part of a larger tour where they inspected numerous other defence establishments including ones in Suffield, Trenton and Ottawa. The BCDRC were provided briefings on Biological and Chemical Defence (BCD) related research at RMCC and CBRN education initiatives. The BCDRC is composed of three members from independent civilian organizations and an executive officer. The names of the committee members:

BGen (Ret’d) J.J. Selbie, executive officer BCDRC.

Dr. Julia M. Foght (Chair), Professor of microbiology in the Department of Biological Sciences at the University of Alberta.

Dr. Mallé Jurima-Romet, from Celerion Inc is an expert in drug development from preclinical to proof-of-concept clinical research for pharmaceutical and biotech companies.

Dr. Pierre G. Potvin, is a faculty member at York University in Toronto.

Members of RMCC who briefed the BCDRC:

Major Paul Hungler; Dr. David Kelly; Dr. Eva Dickson; and Maj Roger Pierce